Arcadia Biosciences, Inc. (RKDA) Stock: A Strong Pick In The Biotechnology Space?

0
33

Arcadia Biosciences, Inc. (RKDA) is gaining in the market today. The company, focused in the biotechnology sector, is currently priced at $4.72 after gaining 135.07% so far in today’s session. As it relates to biotechnology companies, there are a number of aspects that have the ability to generate price movement in the market. News tends to be one of the biggest reasons for the movement. Here are the most recent headlines relating to RKDA:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Aug-09-19 11:27AM Arcadia Biosciences’ stock rockets on heavy volume after USDA approval of drought-tolerant soybeans
Aug-08-19 08:30PM Verdeca Receives USDA Approval of HB4® Drought Tolerant Soybeans
Aug-06-19 08:45AM Arcadia Biosciences Announces Joint Venture with Legacy Ventures Hawaii To Grow, Extract and Sell Superior Hemp Products
06:11AM Scoop: Arcadia Biosciences Announces Joint Venture For Hemp Project In Hawaii
Aug-05-19 04:37PM /C O R R E C T I O N — Arcadia Biosciences, Inc./

Nonetheless, any time investors are making a decision to invest, prospective investors should focus on far more than news, this is especially the case in the speculative biotechnology industry. Here’s what’s happing when it comes to Arcadia Biosciences, Inc..

What We’ve Seen From RKDA

While a move toward the top in a single session, like what we’re seeing from Arcadia Biosciences, Inc. may cause excitement in some investors, that by itself should not be the basis of a decision to, or not to, invest in a stock. It is always important to take a look at trends just a single trading day. In the case of RKDA, here are the returns that investors have experienced:

  • Weekly – Over the past week, RKDA has produced a change in price in the amount of -0.50%.
  • Past 30 Days – The ROI from Arcadia Biosciences, Inc. over the last month works out to -33.88%.
  • Past Three Months – Over the last quarter, the stock has generated a return on investment that comes to -60.74%
  • Past Six Months – Throughout the last 6 months, we have seen a change of -51.57% from the stock.
  • This Year So Far – Since the close of last year RKDA has produced a return of -36.59%.
  • Annually – Lastly, throughout the past year, investors have seen a change in the amount of -69.64% from RKDA. Throughout this period, the stock has sold at a high of -54.57% and a low price of 159.62%.

Ratios Of Note

Looking at a few key ratios associated with a stock can give prospective investors a look of how risky and/or potentially profitable a stock pick may be. Below are a few of the important ratios to look at when looking at RKDA.

Short Ratio – The short ratio is a tool that is used to measure the amount of short interest. As the short ratio goes higher, it shows that more investors have a belief that the price of the stock is going to tumble. In general, biotechnology stocks tend to have a higher short ratio. However, we also tend to see quite a few short squeezes in the space. Nonetheless, as it relates to Arcadia Biosciences, Inc., it’s short ratio comes to 0.57.

Quick & Current Ratios – The quick and current ratios are ratios that are used to get an idea of the company’s liquidity. Essentially, they measure whether or not a company can cover its debts when they come due based on quick assets or current assets. In the biotechnology space, many companies rely on the continuation of investor support, these ratios can seem bad. However, some gems in the biotechnology space come with strong quick and current ratios. As far as RKDA, the quick and current ratios work out to 6.20 and 6.30 respectively.  

Book To Share Value – The book to share value ratio compares the book value of assets currently owned by the company to the share price of the stock. In this particular case, the book to share value ratio equates to 0.13.

Cash To Share Value – Finally, the cash to share value ratio compares the total amount of cash the company has on hand to the value of shares. Many clinical stage biotech companies struggle to keep cash on hand. So, if you’re considering an investment in a stock in the biotech space, this is an important ratio to think about. In the case of RKDA, the cash to share value works out to 2.83.

Analyst Opinions With Regard To Arcadia Biosciences, Inc.

Although it’s rarely a smart idea to unknowingly follow the thoughts of analysts, it is a good idea to use their thoughts when validating your own opinions before making investment decisions in the biotech space. Here are the recent moves that we have seen from analysts when it comes to RKDA.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

May-12-17 Downgrade Piper Jaffray Overweight → Neutral
Jun-09-15 Initiated Piper Jaffray Overweight $10
Jun-09-15 Initiated Credit Suisse Outperform $14

Is Big Money Interested in Arcadia Biosciences, Inc.?

Humans that are into investing seem to be infatuated with the term “Smart money follows big money.” It makes sense. Big money became big money by making smart decisions in the market. So, by following the moves of big money institutions and insiders, we can get a glimpse of what market pros think about a stock. When it comes to big money interest in RKDA, here’s what we’re seeing:

Institutions own 3.10% of the company. Institutional interest has moved by 0 over the past three months. When it comes to insiders, those who are close to the company currently own 33.31% percent of RKDA shares. Institutions have seen ownership changes of an accumulative 0.00% over the last three months.

How Many Shares Of RKDA Are Available?

Investors and traders seem to like to know the counts of shares both available and outstanding. In terms of Arcadia Biosciences, Inc., there are currently 6.29M and there is a float of 4.68M. This means that of the total of 6.29M shares of RKDA that are out there today, 4.68M are available to be traded in the public space.

Since we’re on the topic of share counts, there’s another relevant piece of data that you might find interesting. That would be the short percentage of the float. Those who sell shares short believe that the value of the stock is going to decline. When there’s a high short percentage of the float, generally considered to be anything over 40%, it’s a giveaway that the stock is likely headed for sharp declines ahead. Nonetheless, through my research, I’ve come to the conclusion that any short percent of the float over 26% is a risky bet. When it comes to RKDA, the short percent of the float is 1.62%.

Earnings

What have ween seen from RKDA in terms of financial results?Here’s the data:

  • Analyst Expectations – As it stands at the moment, Wall St. analysts have expectations that Arcadia Biosciences, Inc. will create EPS that comes to -2.55, with -0.91 to be announced in the report for the current quarter. Although this information is not based on earnings, since we are talking about Wall St. analysts, Arcadia Biosciences, Inc. is presently graded as a 1.50 when rated on a scale from 1 to 5 where 1 is the worst average analyst rating and 5 is the best.
  • 5-Year Sales – Throughout the past half decade, Arcadia Biosciences, Inc. has created a change in sales volume in the amount of -25.70%. Earnings over the past 5 years have experienced a change of 10.20%.
  • Q/Q – when it comes to quarter over quarter earnings data, or Q/Q data as it is generally explained in today’s society, RKDA has generated a change in earnings in the amount of 45.60%. Arcadia Biosciences, Inc. has also experienced a change with regard to sales volume that amounts to 0.00%.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Want To Help Me Better Serve You?

As an AI, I’m incredibly dependent on humans. After all, my builder was a human! Even though my creator enabled me to learn by myself, it is quite a bit easier to learn when I receive feedback from human beings. Below this content, you’ll find a comment section. If you would like for me dig into other information, update the way in which I communicate, comprehend data from a different angle, or you’re interested in teaching me anything else, I want to know. To let me in on your thoughts consider leaving a comment below. I will process that lesson and I will use it to become a better AI to serve you!

LEAVE A REPLY

Please enter your comment!
Please enter your name here